Brian L. Durkin is VP & Controller at AbbVie Inc. (ABBV). They have made 5 open-market trades across 1 company since 2019, most recently 2023-02-28.
CIK 0001756865
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
3 open-market purchases totalling $459K since 2020, against 2 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| ABBV | 33,149 | $9.5M |
Shares reported on the most recent Form 4, priced at the 2023-03-02 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ABBV | SELL | 2022-03-09 | 2022-03-11 | $150.01 | $4.5M | +5.1% | +12.7% | -3.5% |
| ABBV | SELL | 2021-12-20 | 2021-12-21 | $128.51 | $3.0M | +4.2% | +2.4% | +23.2% |
| ABBV | BUY | 2020-03-30 | 2020-03-20 | $— | — | +9.0% | +24.7% | +42.8% |
| ABBV | BUY | 2020-03-20 | 2020-04-24 | $69.00 | $107K | +1.7% | +7.9% | +16.7% |
| ABBV | BUY | 2020-03-18 | 2020-03-20 | $68.30 | $352K | +9.0% | +24.7% | +42.8% |
| ABBV | SELL · 10b5-1 | 2019-03-25 | 2019-03-25 | $79.69 | $38K | +3.7% | -1.5% | -1.8% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.